Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 390-395

  Aguilar, Eduardo ^a   García Díaz, Ana María ^b   Sánchez Muñoz Torrero, Juan Francisco ^c   Álvarez, Lorenzo Ramón ^d   Piedecausa, Mar ^e   Arnedo, Gemma ^f   Monreal, Manuel ^f  

^a Hospital de Alcañiz Alcañiz   (Spain)

^b Primary Healthcare   (Spain)

^c HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^d HOSPITAL DE TERRASSA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anticoagulants; Antiplatelets; Atrial fibrillation; Atroke; Ayocardial infarction; Bleeding

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DISEASE REGISTRY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CAUSALITY; CEREBROVASCULAR DISORDERS; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; PERIPHERAL ARTERIAL DISEASE; REGISTRIES; SPAIN; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84865224357     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.05.016     Document Type: Article

References (30)

1. Z. Khoury, R. Schwartz, S. Gottlieb, A. Chenzbraun, S. Stern, and A. Keren Relation of coronary artery disease to atherosclerotic disease of the aorta, carotid, and femoral arteries evaluated by ultrasound Am J Cardiol 80 1997 1429 1433
2. L.M. Brass, P.M. Hartigan, W.F. Page, and J. Concato Importance of cerebrovascular disease in adults with myocardial infarction Stroke 27 1996 1173 1176
3. J.M. Murabito, R.B. D'Agostino, H. Silbershatz, and W.F. Wilson Intermittent claudication: a risk profile from the Framingham Heart Study Circulation 96 1997 44 49
4. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people BMJ 324 2002 71 86
5. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
6. A.J. Camm, P. Kirchhof, G.Y.H. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial fibrillation. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
7. R.G. Hart, O. Benavente, R. McBride, and L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
8. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation Ann Intern Med 146 2007 857 867
9. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
10. G.C. Flaker, M. Gruber, S.J. Connolly, S. Goldman, S. Chaparro, and A. Vahanian SPORTIF Investigators. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Am Heart J 152 2006 967 973
11. M.L. Hansen, R. Sorensen, M.T. Clausen, M.L. Fog-Petersen, J. Raunso, and N. Gadsboll Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
12. G. Mazzaglia, A. Filippi, M. Alacqua, W. Cowell, A. Shakespeare, and L.G. Mantovani A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care Thromb Haemost 103 2010 968 975
13. I.M. Ogilvie, N. Newton, S.A. Welner, W. Cowell, and G.Y. Lip Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645
14. R. Barba, J. Bisbe, J.N. Pedrajas, J. Toril, R. Monte, and J.F. Muñoz-Torrero Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: Findings from the FRENA Registry Eur J Cardiovasc Prev Rehabil 17 2009 456 463
15. T. Gadelha, J. Bisbe, J. Toril, J.N. Alcalá Pedrajas, and M. Monreal Major bleeding events in stable outpatients with coronary, cerebrovascular, or peripheral artery disease: Findings from the FRENA Registry J Thromb Haemost 7 2009 1414 1416
16. M. Camafort, L.R. Alvarez-Rodríguez, J.F. Muñoz-Torrero, J.C. Sahuquillo, L. López-Jiménez, and R. Coll Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry Diabet Med 28 2011 73 80
17. J.F. Muñoz-Torrero, D. Escudero, C. Suárez, C. Sanclemente, M.T. Pascual, and J. Zamorano Concomitant use of proton-pump inhibitors and clopidogrel in patients with coronary, cerebrovascular, or peripheral artery disease in the FRENA Registry J Cardiovasc Pharmacol 57 2011 13 19
18. A.M. García-Díaz, P.J. Marchena, J. Toril, and G. Arnedo Sánchez Muñoz-Torrero JF, Yeste M, Aguilar E, Monreal M. Alcohol consumption and outcome in stable outpatients with peripheral artery disease J Vasc Surg 54 2011 1081 1087
19. J.A. Dormandy, and B. Rutherford Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC) J Vasc Surg 31 2000 S1 S96
20. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
21. G.Y.H. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J.G.M. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor approach: the Euro heart survey on atrial fibrillation Chest 137 2010 263 272
22. G.Y.H. Lip, L. Frison, J.L. Halperin, and D.A. Lane Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/alcohol concomitantly) score J Am Coll Cardiol 57 2011 173 180
23. D.O. Martin, and H. Austin Exact estimates for a rate ratio Epidemiology 7 1996 29 33
24. D.R. Holmes Jr., D.J. Kereiakes, N.S. Kleiman, D.J. Moliterno, G. Patti, and C.L. Grines Combining antiplatelet and anticoagulant therapies J Am Coll Cardiol 54 2009 95 109
25. B.G. Vickrey, T.S. Rector, S.L. Wickstrom, P.M. Guzy, E.M. Sloss, and P.B. Gorelick Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease Stroke 33 2002 901 906
26. D.L. Brown, L.D. Lisabeth, C. Roychoudhury, Y. Ye, and L.B. Morgenstern Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack Stroke 36 2005 1285 1287
27. E. Touzé, O. Varenne, G. Chatellier, S. Peyrard, P.M. Rithwell, and J.L. Mas Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke. A systematic review and meta-analysis Stroke 36 2005 2748 2755
28. J. Bassand, C. Hamm, D. Ardissino, E. Boersma, A. Budaj, and F. Fernández-Avilés Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
29. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, and V. Falk Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
30. D.P. Faxon, J.W. Eikelboom, P.B. Berger, D.R. Holmes, D.L. Bhatt, and D.J. Moliterno Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting Thromb Haemost 106 2011 571 584